SCHEMBL285618

SCHEMBL285618

CCOC(=O)c1cccc(N)c1.CS(=O)(=O)O

nearest known ligand 0.54

Known targets — ChEMBL curated mechanism

ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 known ✓ P07550 2/20 0.53
LMNA P02545 2/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
MAOA P21397 1/20 0.54
ELANE P08246 1/20 0.54
ADRB1 P08588 2/20 0.53
ADRB3 P13945 2/20 0.53
CA2 P00918 3/20 0.51
CDC25B P30305 2/20 0.51
CA1 P00915 2/20 0.51
CA12 O43570 1/20 0.51
CA9 Q16790 1/20 0.51
HPGD P15428 1/20 0.50
RECQL P46063 1/20 0.50
CYP4F2 P78329 1/20 0.50
CYP4A11 Q02928 1/20 0.50
ALDH1A1 P00352 1/20 0.50
TSHR P16473 1/20 0.50
KMT2A Q03164 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29370485 1.00 LMNA (0.54) LMNACYP1A2CYP3A4MAOAELANE
SCHEMBL983965 1.00 LMNA (0.54) LMNACYP1A2CYP3A4MAOAELANE
Methane SCHEMBL2132580 0.98 ELANE (0.53) LMNACYP1A2CYP3A4MAOAELANE
Hydrochloric Acid SCHEMBL7319745 0.98 ELANE (0.53) LMNACYP1A2CYP3A4MAOAELANE
SCHEMBL29465556 0.92 LMNA (0.62) LMNACYP1A2CYP3A4MAOAELANE
SCHEMBL133366 0.92 LMNA (0.62) LMNACYP1A2CYP3A4MAOAELANE
Methane SCHEMBL15286491 0.91 LMNA (0.61) LMNACYP1A2CYP3A4MAOAELANE
Hydrochloric Acid SCHEMBL642777 0.91 LMNA (0.61) LMNACYP1A2CYP3A4MAOAELANE
Ethylamine SCHEMBL27494386 0.88 LMNA (0.57) LMNACYP1A2CYP3A4MAOAELANE
3-Aminobenzoic Acid SCHEMBL8220213 0.86 LMNA (0.56) LMNACYP1A2CYP3A4MAOAELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2966 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122074420-A Evaluation method of bile acid in relieving intestinal inflammation of east star spots 2026-05-26 CN claimed
CN-121674260-B Microorganism composite flora for treating aquaculture tail water and application thereof 南京万瑞环境科技有限公司 2026-05-19 CN claimed
CN-119769445-B Method for improving fish muscle quality by regulating intestinal microenvironment through neuroendocrine system 湖北省农业科学院农产品加工与核农技术研究所 2026-05-19 CN claimed
EP-4436552-B1 GASTRO-RETENTIVE ORAL DOSAGE UNIT CONTAINING A LOCAL ANAESTHETIC OREXA B V (NL) 2026-02-04 EP claimed
US-20250185632-A1 CONTINUOUS IN-SITU THERAPEUTIC TREATMENT SYSTEM FOR FISH IN FRESHWATER, FROM SEAWATER Salmoclinic Spa (CL) 2025-06-12 US claimed
CN-119950421-A Anesthetic preparation containing tricaine and preparation method thereof 北华大学 2025-05-09 CN claimed
CN-119867222-A Growth regulator and application thereof in Babylonia cultivation 广东海洋大学 2025-04-25 CN claimed
CN-119769445-A Method for improving fish muscle quality by regulating intestinal microenvironment through neuroendocrine system 湖北省农业科学院农产品加工与核农技术研究所 2025-04-08 CN claimed
CN-119587525-A Dimethocaine composite preparation and preparation method thereof 海南三帝制药有限公司 2025-03-11 CN claimed
WO-2025043048-A1 METHODS AND SYSTEMS FOR DELIVERY OF MODIFIED AGAROSE POLYSACCHARIDES RELIVE THERAPEUTICS INC. (US) 2025-02-27 WO claimed
EP-1480677-A2 COMPOSITION FOR STABILIZING HYALURONIC ACID IOLTECH (FR) 2004-12-01 EP claimed
US-20030133986-A1 Compositions for stabilizing poly (carboxylic acids) TSAO FU-PAO (US) 2003-07-17 US claimed
WO-2003043660-A2 COMPOSITION FOR STABILIZING HYALURONIC ACID NOVARTIS AG (CH) 2003-05-30 WO claimed
WO-2002067898-A1 PROLONGATION OF CHEMICAL ACTIVITY OF FLAVORANTS AND THERAPEUTICS WITH CETYL PYRIDINIUM CHLORIDE SDG, INC. (US) 2002-09-06 WO claimed
EP-1027015-A4 CONTROLLED RELEASE OF PHARMACEUTICALS IN THE ANTERIOR CHAMBER OF THE EYE GALIN MILES A (US) 2001-06-27 EP claimed
US-6207192-B1 Prolongation of chemical activity of flavorants and therapeutics with cetyl pyridinium chloride SDG, INC. 2001-03-27 US claimed
EP-1027015-A1 CONTROLLED RELEASE OF PHARMACEUTICALS IN THE ANTERIOR CHAMBER OF THE EYE Galin, Miles A. (US) 2000-08-16 EP claimed
CN-1251979-A Controlled release of drugs in the anterior chamber of the eye MILES A GALIN (US) 2000-05-03 CN claimed
US-5972326-A Controlled release of pharmaceuticals in the anterior chamber of the eye IOLTECH (FR) 1999-10-26 US claimed
WO-1998041171-A1 CONTROLLED RELEASE OF PHARMACEUTICALS IN THE ANTERIOR CHAMBER OF THE EYE GALIN MILES A (US) 1998-09-24 WO claimed